BeOne Medicines AG - Depositary Receipt (Common Stock)
US ˙ NasdaqGS ˙ US07725L1026

SecurityONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
InstitutionCitigroup Inc
Latest Disclosed Ownership10,188 shares
Latest Disclosed Value $ 3,025,530
Citigroup Inc ownership in ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 10,188 shares of BeOne Medicines AG - Depositary Receipt (Common Stock) (US:ONC) valued at $3,025,530 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 5,598 shares of BeOne Medicines AG - Depositary Receipt (Common Stock). This represents a change in shares of 81.99% during the quarter. The current value of the position is $2,842,452 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (ONC) in the form of stock options. The firm currently holds call options representing 14,000 of underlying shares valued at $4,157,580 USD and put options representing 14,000 of underlying shares valued at $4,157,580 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ONC / BeOne Medicines AG - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F BEONE MEDICINES SPONSORED ADS 07725L102 10,188 4,590 81.99 3,026 77.94 0.0006
2026-02-13 2025-12-31 13F BEONE MEDICINES SPONSORED ADS 07725L102 5,598 -871 -13.46 1,701 -22.83 0.0008
2025-11-10 2025-09-30 13F BEONE MEDICINES SPONSORED ADS 07725L102 6,469 1,720 36.22 2,204 91.73 0.0010
2025-08-11 2025-06-30 13F BEONE MEDICINES SPONSORED ADS 07725L102 4,749 -11,070 -69.98 1,150 -73.31 0.0006
2025-05-12 2025-03-31 13F BEIGENE SPONSORED ADS 07725L102 15,819 -4,853 -23.48 4,305 12.76 0.0022
2025-02-12 2024-12-31 13F BEIGENE SPONSORED ADR 07725L102 20,672 -5,640 -21.44 3,818 -35.36 0.0023
2024-11-12 2024-09-30 13F BEIGENE SPONSORED ADR 07725L102 26,312 5,410 25.88 5,907 98.09 0.0034
2024-08-12 2024-06-30 13F BEIGENE SPONSORED ADR 07725L102 20,902 12,701 154.87 2,982 132.61 0.0019
2024-05-10 2024-03-31 13F BEIGENE SPONSORED ADR 07725L102 8,201 2,934 55.71 1,283 35.09 0.0008
2024-02-09 2023-12-31 13F BEIGENE SPONSORED ADR 07725L102 5,267 2,508 90.90 950 91.33 0.0007
2023-12-06 2023-09-30 13F/A-1 BEIGENE SPONSORED ADR 07725L102 2,759 -495 -15.21 496 -14.48 0.0004
2023-11-09 2023-09-30 13F BEIGENE SPONSORED ADR 07725L102 2,759 -495 496 0.0001
2023-08-10 2023-06-30 13F BEIGENE SPONSORED ADR 07725L102 3,254 491 17.77 580 -2.52 0.0004
2023-05-11 2023-03-31 13F BEIGENE SPONSORED ADR 07725L102 2,763 391 16.48 596 14.20 0.0004
2023-02-09 2022-12-31 13F BEIGENE SPONSORED ADR 07725L102 2,372 -7,525 -76.03 522 -60.97 0.0004
2022-11-10 2022-09-30 13F BEIGENE SPONSORED ADR 07725L102 9,897 -6,999 -41.42 1,335 -51.19 0.0010
2022-08-10 2022-06-30 13F BEIGENE SPONSORED ADR 07725L102 16,896 -1,110 -6.16 2,735 -19.46 0.0020
2022-05-12 2022-03-31 13F BEIGENE SPONSORED ADR 07725L102 18,006 -9,619 -34.82 3,396 -54.63 0.0021
2022-02-10 2021-12-31 13F BEIGENE SPONSORED ADR 07725L102 27,625 2,269 8.95 7,485 -18.69 0.0040
2021-11-10 2021-09-30 13F BEIGENE SPONSORED ADR 07725L102 25,356 87 0.34 9,205 6.13 0.0054
2021-08-10 2021-06-30 13F BEIGENE SPONSORED ADR 07725L102 25,269 -4,229 -14.34 8,673 -15.53 0.0052
2021-05-13 2021-03-31 13F BEIGENE SPONSORED ADR 07725L102 29,498 -5,588 -15.93 10,267 13.26 0.0066
2021-02-11 2020-12-31 13F BEIGENE SPONSORED ADR 07725L102 35,086 17,136 95.47 9,065 76.29 0.0054
2020-11-12 2020-09-30 13F BEIGENE SPONSORED ADR 07725L102 17,950 -515 -2.79 5,142 47.76 0.0034
2020-08-12 2020-06-30 13F BEIGENE SPONSORED ADR 07725L102 18,465 145 0.79 3,480 54.26 0.0027
2020-05-12 2020-03-31 13F BEIGENE SPONSORED ADR 07725L102 18,320 -22,618 -55.25 2,256 -66.76 0.0020
2020-02-12 2019-12-31 13F BEIGENE SPONSORED ADR 07725L102 40,938 -75,857 -64.95 6,787 -52.55 0.0049
2019-11-08 2019-09-30 13F BEIGENE SPONSORED ADR 07725L102 116,795 64,982 125.42 14,302 122.67 0.0113
2019-08-12 2019-06-30 13F BEIGENE SPONSORED ADR 07725L102 51,813 -19,273 -27.11 6,423 -31.54 0.0052
2019-05-13 2019-03-31 13F BEIGENE SPONSORED ADR 07725L102 71,086 -17,505 -19.76 9,382 -24.50 0.0090
2019-02-12 2018-12-31 13F BEIGENE SPONSORED ADR 07725L102 88,591 -38,510 -30.30 12,426 -43.23 0.0126
2018-11-13 2018-09-30 13F BEIGENE SPONSORED ADR 07725L102 127,101 2,298 1.84 21,890 14.09 0.0195
2018-08-10 2018-06-30 13F BEIGENE SPONSORED ADR 07725L102 124,803 -1,067 -0.85 19,186 -9.27 0.0176
2018-05-11 2018-03-31 13F BEIGENE SPONSORED ADR 07725L102 125,870 -697 -0.55 21,146 70.97 0.0174
2018-02-12 2017-12-31 13F BEIGENE SPONSORED ADR 07725L102 126,567 58,930 87.13 12,368 76.74 0.0099
2017-11-13 2017-09-30 13F BEIGENE SPONSORED ADR 07725L102 67,637 66,803 8,009.95 6,998 18,315.79 0.0057
2017-08-11 2017-06-30 13F BEIGENE SPONSORED ADR 07725L102 834 -327 -28.17 38 -11.63 0.0000
2017-05-12 2017-03-31 13F BEIGENE SPONSORED ADR 07725L102 1,161 490 73.03 43 115.00 0.0000
2017-02-10 2016-12-31 13F BEIGENE SPONSORED ADR 07725L102 671 671 20 0.0000
2016-08-12 2016-06-30 13F BEIGENE SPONSORED ADR 07725L102 0 -2 -100.00 0 0.0000
2016-05-13 2016-03-31 13F BEIGENE SPONSORED ADR 07725L102 2 2 0 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F BEONE MEDICINES SPONSORED ADS Call 14,000 -30.00 4,158 -31.58 n/a n/a n/a
2026-02-13 2025-12-31 13F BEONE MEDICINES SPONSORED ADS Call 20,000 0.00 6,076 -10.83 n/a n/a n/a
2025-11-10 2025-09-30 13F BEONE MEDICINES SPONSORED ADS Call 20,000 6,814 n/a n/a n/a
2025-05-12 2025-03-31 13F BEIGENE SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-12 2024-12-31 13F BEIGENE SPONSORED ADR Call 29,900 5,523 n/a n/a n/a
2024-11-12 2024-09-30 13F BEIGENE SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-12 2024-06-30 13F BEIGENE SPONSORED ADR Call 15,000 2,140 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F BEONE MEDICINES SPONSORED ADS Put 14,000 -30.00 4,158 -31.58 n/a n/a n/a
2026-02-13 2025-12-31 13F BEONE MEDICINES SPONSORED ADS Put 20,000 0.00 6,076 -10.83 n/a n/a n/a
2025-11-10 2025-09-30 13F BEONE MEDICINES SPONSORED ADS Put 20,000 6,814 n/a n/a n/a
2025-05-12 2025-03-31 13F BEIGENE SPONSORED ADR Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-12 2024-12-31 13F BEIGENE SPONSORED ADR Put 29,900 5,523 n/a n/a n/a
2024-11-12 2024-09-30 13F BEIGENE SPONSORED ADR Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-12 2024-06-30 13F BEIGENE SPONSORED ADR Put 15,000 2,140 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.